Sigma Planning Corp Evogene Ltd. Transaction History

Sigma Planning Corp

$3.11 Billion
Q1 2024

A detailed history of Sigma Planning Corp transactions in Evogene Ltd. stock. As of the latest transaction made, Sigma Planning Corp holds 31,785 shares of EVGN stock, worth $20,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,785

Previous 23,087 37.67%

Holding current value

$20,660

Previous $19,000 21.05%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$0.7 - $0.98 $6,088 - $8,524	8,698 Added 37.67%	31,785 $23,000
Q4 2023 Feb 01, 2024	SELL	$0.47 - $0.88 $13,112 - $24,550	-27,898 Reduced 54.72%	23,087 $19,000
Q3 2023 Nov 06, 2023	BUY	$0.58 - $1.41 $3,503 - $8,517	6,041 Added 13.44%	50,985 $30,000
Q2 2023 Aug 01, 2023	SELL	$0.56 - $1.2 $591 - $1,267	-1,056 Reduced 2.3%	44,944 $48,000
Q1 2023 May 05, 2023	BUY	$0.59 - $0.86 $375 - $547	637 Added 1.4%	46,000 $28,000

Q3 2022 Nov 10, 2022	BUY	$0.73 - $1.27 $9,893 - $17,212	13,553 Added 42.61%	45,363 $38,000
Q2 2022 Aug 11, 2022	BUY	$0.75 - $1.33 $300 - $532	400 Added 1.27%	31,810 $24,000
Q1 2022 Apr 20, 2022	BUY	$1.09 - $1.83 $16,023 - $26,901	14,700 Added 87.97%	31,410 $41,000
Q4 2021 Feb 02, 2022	SELL	$1.63 - $2.83 $5,542 - $9,622	-3,400 Reduced 16.91%	16,710 $27,000
Q3 2021 Oct 28, 2021	SELL	$2.45 - $3.45 $12,250 - $17,250	-5,000 Reduced 19.91%	20,110 $53,000
Q2 2021 Aug 13, 2021	SELL	$3.3 - $5.02 $1,320 - $2,007	-400 Reduced 1.57%	25,110 $86,000
Q1 2021 May 06, 2021	BUY	$4.29 - $9.94 $57,915 - $134,190	13,500 Added 112.41%	25,510 $129,000
Q4 2020 Feb 09, 2021	BUY	$2.41 - $5.63 $28,944 - $67,616	12,010 New	12,010 $56,000

Others Institutions Holding EVGN

# of Institutions

Shares Held

4.08M

Call Options Held

23K

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $26.8M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Evogene Ltd. Transaction History